← Back to Search

Digital Health Intervention for Preventing Childhood Obesity

N/A
Waitlist Available
Led By Melissa C Kay, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English or Spanish speaking
At least 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 32 weeks gestation to 3 months postpartum
Awards & highlights

Study Summary

This trial tests a text messaging intervention to help new mothers enrolled in WIC with breastfeeding and responsive bottle feeding.

Who is the study for?
This trial is for mothers who plan to breastfeed or are undecided, enrolled in WIC, speak English/Spanish, at least 18 years old, between 18-28 weeks pregnant and willing to text daily. Excluded are those with medical issues affecting breastfeeding or whose infants have prematurity (<37 weeks), spent >3 days in NICU, or weigh <5 lbs.Check my eligibility
What is being tested?
The study tests a digital intervention using text messaging to support infant feeding among WIC-enrolled mothers. It starts prenatally and continues until the baby is three months old. The goal is to promote responsive bottle feeding and longer exclusive breastfeeding.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention (text messaging), there aren't typical side effects like with drugs; however, participants may experience increased screen time which could affect sleep patterns or cause mild eye strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You agree to send and receive daily text messages.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~32 weeks gestation to 3 months postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and 32 weeks gestation to 3 months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Engagement
Secondary outcome measures
Breastfeeding duration

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Interactive text messages that include goal setting, tailored feedback, and skills training.
Group II: ControlActive Control1 Intervention
Text4Baby
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention
2011
Completed Phase 4
~73780

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,069 Total Patients Enrolled
Melissa C Kay, PhDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
60 Total Patients Enrolled

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05265845 — N/A
Breastfeeding Research Study Groups: Control, Intervention
Breastfeeding Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05265845 — N/A
Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05265845 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research actively seeking participants at present?

"According to clinicaltrials.gov, this medical trial is no longer collecting participants; it was first posted on July 14th 2022 and the information was last updated four weeks later. However, 262 other studies are still actively recruiting patients."

Answered by AI
~0 spots leftby Jul 2024